shiruken OP t1_j5w05gq wrote
Reply to comment by Alex_of_Bree in The bivalent mRNA boosters from Pfizer-BioNTech and Moderna were 48% effective against symptomatic infection from the predominant omicron subvariant (XBB/XBB.1.5) in persons aged 18-49 years according to early data published by the CDC by shiruken
That would likely require an updated vaccine to account for mutations in the latest predominant variants.
Sufficient-Ad6 t1_j5xauva wrote
I'm quintuple vaxxed and intend to continue collecting the whole set.
drosen32 t1_j5xbnrs wrote
I’d be on the monthly vaccine plan if there was one.
Sufficient-Ad6 t1_j5xc506 wrote
Honestly. I'm immuno-compromised and at the height of lockdowns I would have let them inject me with bone marrow and toast crumbs if it would have helped.
[deleted] t1_j5xhy4v wrote
[removed]
[deleted] t1_j5xijr6 wrote
[removed]
PHealthy t1_j5weh0y wrote
It's good to remember that vaccination coverage is just as important as efficacy.
shiruken OP t1_j5wfgxv wrote
Unfortunately only 15.3% coverage for the bivalent booster dose.
kolitics t1_j5wcgie wrote
Assuming the remaining 52% is coming from mutation and not time since booster or other factors.
Alex_of_Bree t1_j5w0big wrote
Probably. I'm sure it will happen sooner than not at all
Viewing a single comment thread. View all comments